ImmuLogic Pharmaceutical Corp. (Abridged) Harvard Case Solution & Analysis

ImmuLogic Pharmaceutical Corporation, the development stage biotechnology company, is considering IPO of common stock. Studies and the problem of high-tech start-ups in these cases. Problems associated with the "windows" for the public offering of shares will be allocated. "Hide
by Josh Lerner Source: Harvard Business School 25 pages.

immulogic pharmaceutical corporation case solution

immulogic pharmaceutical corporation case solution

Publication Date: December 9, 1992. Prod. #: 293087-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.